Thomas Meier becomes new CEO of Medios AG
The Supervisory Board of Medios AG has appointed Thomas Meier as CEO effective February 1, 2026. He succeeds Matthias Gaertner, who will remain in office until the end of 2025.
The Supervisory Board of Medios AG has appointed Thomas Meier as CEO effective February 1, 2026. He succeeds Matthias Gaertner, who will remain in office until the end of 2025.
Renowned dentist and author Dr. Johanna Graf becomes Deputy Chair of the Scientific Advisory Board at BEYOND FLUORID, reinforcing the initiative’s scientific independence.
The Federal Assembly of the German Dental Association has elected Dr. Romy Ermler as its new President. Together with Dr. Ralf Hausweiler and Dr. Doris Seiz, she will lead the new Executive Board.
Nearly two-thirds of Germans rate current long-term care as inadequate, and almost 90% demand an affordable care system for everyone – according to a new DAK-Gesundheit study by the Allensbach Institute.
The M-Boltz Hackathon by Merck and the Boltz team has set a new benchmark for open, AI-driven innovation in drug discovery through global collaboration and groundbreaking results.
With its new Instagram channel “checkt.mann”, the University Medical Center Freiburg aims to raise awareness among men about physical and mental health – honest, humorous, and science-based.
Effective November 1, Philipp Brunner joins Plan.Net Group as the new CFO, succeeding Dr. Ingo Stein. He will oversee all financial operations and strengthen the group’s digital finance strategy.
Ardena expands its leadership team with the appointment of Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer – reinforcing its global commitment to quality, compliance, and digital excellence.
Chiesi’s leadership team is growing: With Christine Contré and Sven Noffke, Chiesi gains two experienced professionals in Medical Affairs and Legal & Compliance.
SCHOTT Pharma launches its first 5.5 ml prefillable glass syringe – a key innovation supporting home therapies and large-volume biologics.